Scroll to Top
/ Press Releases & Statements
Press Releases & Statements
Christopher A. Viehbacher, CEO of Sanofi, designated new President elect of EFPIA
06 November 2012
06.11.2012, Brussels: EFPIA is delighted to announce the designation of Christopher A. Viehbacher, Chief Executive Officer of Sanofi as the new President elect of EFPIA. He ...
EFPIA statement on Healthcare professionals
16 October 2012
Brussels, 16 Ocotober 2012: EFPIA is committed to building trust in how the pharmaceutical industry conducts its business and interacts with key stakeholders. For that reason we ...
EFPIA welcomes Commission decision for a policy strategy agenda to strengthen the competitiveness of the pharmaceutical industry
11 October 2012
Need for concrete measures at national level to help stimulate innovation and ensure access for all European patients to modern ...
Stem cells discovery gets Nobel Prize
09 October 2012
11.10.2012, Brussels: EFPIA would like to congratulate Sir John Gurdon and Shinya Yamanaka for winning this year’s Nobel Prize of medicine for their work on the ...
Interpol crackdown on illicit online pharmacies
08 October 2012
11.10.2012, Brussels: Interpol last week announced the seizure of over 3.75million units of counterfeit medicines worth over 10million USD. Operation Pangea V - the largest internet ...
Launch of online resource for challenging drug patents by MSF
05 October 2012
On Tuesday 2nd October MSF launched an online resource to help civil society groups and patient groups in developing countries to challenge unwarranted drug patents through patent ...
Global pharmaceutical industry calls for broad-based cooperation to fight online sales of counterfeit medicines around the world
24 July 2012
Four major pharmaceutical associations issue joint policy statement to crack down on counterfeits from illicit Internet pharmacies and other sources Statement comes as the U.S. launches ...
"Reform of EU Clinical Trials Rules - Europe can’t afford to fail!", says Richard Bergström.
17 July 2012
EFPIA welcomes the proposal for a new Regulation on Clinical Trials on Medicinal Products for Human Use adopted today by the European Commission as a ...
President of EFPIA calls for pharma innovation to be a key part of a European growth strategy
27 June 2012
Brussels, 27 June 2012: Sir Andrew Witty, CEO of GlaxoSmithKline and President of EFPIA, the body representing the research-based pharmaceutical industry in Europe, called today ...
EU Pharmaceutical industry leaders call for revision of German model for assessment of new medicines
08 June 2012
In today's meeting in Berlin the leading pharmaceutical companies of Europe, represented in EFPIA, asked the German Government for urgent action to protect patient access ...
Page 19 of 21
Press Releases & Statements
Enabling Technologies for Better Patient Outcomes - Live Streaming
Facts & Figures
Follow us on
Add us on
Check us out on
EFPIA Brussels Office
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
European Biopharmaceutical Enterprises
INNOVATIVE MEDICINES INITIATIVE
Educational Events & Ethical Evaluation
EFPIA 2017 - All rights reserved -
- Design by
Morris & Chapman